CGM use tied to similar odds for pregnancy outcomes as self-monitoring blood glucose
Use of real-time continuous glucose monitoring did not improve perinatal outcomes among women with gestational diabetes, according to findings from a randomized controlled trial published in The Lancet Diabetes & Endocrinology. In an open-label trial conducted in Switzerland, pregnant women with gestational diabetes were randomly assigned to Dexcom G6 real-time CGM or self-monitoring blood